Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
Bevacizumab and the antimetabolites capecitabine and gemcitabine have been shown to improve outcomes when added to taxanes in patients with metastatic breast cancer. The primary aims of this trial were to determine whether the addition of capecitabine or gemcitabine to neoadjuvant chemotherapy with...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | engelsk |
| Udgivet: |
2012
|
| Online adgang: | https://doi.org/10.1056/nejmoa1111097 http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|